Biocardia to host q1 2024 financial results and corporate update conference call on may 14, 2024

Sunnyvale, calif., may 09, 2024 (globe newswire) -- biocardia®, inc. [nasdaq:bcda], a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today announced it will report its financial results for the the three months ended march 31, 2024 and provide a corporate update by conference call on tuesday, may 14, 2024 at 4:30 pm et. following management's formal remarks, there will be a question-and-answer session.
BCDA Ratings Summary
BCDA Quant Ranking